As Global Head of Operations, World Without Disease Accelerator (WWDA), Rae Ann has overall strategy realization and operational responsibility for the WWDA and the Lung Cancer Initiative at Johnson & Johnson. Her team delivers strategic planning, business operations, program management, operational excellence and external alliance management for cross-sector initiatives focused on preventing, intercepting or curing disease.
Rae Ann has over 20 years of experience in healthcare, including 15+ years at Johnson & Johnson, where she has led quality, innovation, operations and strategy functions in all three sectors. Prior to leading strategy and operations for cross-sector R&D initiatives, Rae Ann was the head of Strategy, Insights & Innovation for the Global Quality Services organization. Prior to that, Rae Ann was an Innovation Leader in Consumer R&D where she focused on developing a digital health platform to improve health outcomes and quality of life for women during pregnancy. Rae Ann also spent 3 years leading Quality, Regulatory, Compliance and Operations on the Wellness and Prevention leadership team. Prior to that, Rae Ann was part of an internal “startup” where she obtained FDA clearance for the InTouch diabetes management solution. Rae Ann started her J&J career as a Quality Director with McNeil, where her responsibilities included Consumer QA strategy, IT Compliance and External Manufacturing QA. Before joining J&J, Rae Ann held various leadership roles at Pfizer and Merck.
Rae Ann holds a B.S. in Neuroscience from the University of Scranton and an M.S. in Engineering from Lehigh University.